Angita Pharmaceuticals and Motac enter into a joint research collaboration
Tuesday 25 November 2014
- Life Cooperative
Angita Pharmaceuticals and Motac enter into a joint research collaboration to evaluate AG-0029, a putative treatment for both the motor and cognitive symptoms in Parkinson’s disease.
AG-0029, a combined dopamine D2 receptor agonist and histamine H3 receptor antagonist, was discovered by Angita and has been shown to have cognitive enhancing potential and PD-related motor improvements in rodent models. Motac will invest in the project to extend the existing proof-of-concept studies including evaluation of Parkinson’s disease-related motor and cognitive disturbances in the most relevant and translational models. Jointly, Angita and Motac aim to ensure the continued development of AG-0029, raising funds to initiate additional non-clinical development studies.
About Angita Pharmaceuticals
Angita is a virtual drug discovery company with a pipeline of innovative new chemical entities addressing unmet clinical needs. We collaborate with academic institutes and early spin-outs applying our discovery expertise with the goal of partnering, out-licensing or spinning-out drug development candidates at pre-clinical development stage.
Motac is a preclinical research company dedicated to working with pharmaceutical and biotechnology companies that are developing new treatments for diseases of the central nervous system. As a company, we have unparalleled expertise in the fields of movement disorders, such as Parkinson’s disease and dyskinesias, and in the fields of neuropsychology and cognition.
Focus areasLife Cooperative
Thursday 29 August 2019
CC Diagnostics final 'Jonge Ondernemingsprijs'
Wednesday 3 July 2019
Biomarkers in Groningen set the tone nationwide
Tuesday 7 May 2019
Ofinext first with production medicinal cannabis oil
Friday 26 April 2019
CC Diagnostics and EV Biotech nominated for most pioneerin..
Tuesday 16 April 2019
New building Polyganics on Zernike Campus
Wednesday 13 March 2019
Enthusiastic crowd Beta Business Days 2019
Tuesday 26 February 2019
Ofichem in TV program ZEMBLA
Wednesday 6 February 2019
High presence talent at Meet&Greets 2019
Wednesday 30 January 2019
LIFE Cooperative: ‘An important ecosystem in the field of ..
Tuesday 15 January 2019
InnoCore Pharmaceuticals will develop contraceptive micron..